QUOTE AND NEWS
Motley Fool  Apr 27  Comment 
Ziopharm Oncology shares are heading lower as investors book profits after a big move this year.
TheStreet.com  Apr 20  Comment 
NEW YORK (TheStreet) -- Shares of Ziopharm Oncology  fell 7.68% to $11 in afternoon trading Monday after so-called CAR-T cellular therapies for solid tumors showed mediocre results at a conference on Sunday. Ziopharm is currently working with...
TheStreet.com  Apr 2  Comment 
BOSTON (TheStreet) -- Welcome to the pre-Passover/Easter Biotech Stock Mailbag. May you get your fill of matzoh and Peeps this weekend.  @adamfeuerstein Looks like good news $NWBO — Jeffrey Feldman (@JeffreyFeldman5) March 27, 2015 ...
Motley Fool  Mar 30  Comment 
Merck Serono is teaming up with Intrexon Corp and Ziopharm Oncology, Inc. on CAR-T immunotherapies.
Motley Fool  Mar 25  Comment 
Ziopharm Oncology Inc.'s shares are retreating following a more than doubling since January.
TheStreet.com  Mar 11  Comment 
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of Jim Cramer, TheStreet, Inc., or any of its contributors.  TheStreet Ratings quantitative algorithm evaluates over 4,300 stocks on...
TheStreet.com  Feb 24  Comment 
NEW YORK -- Bullish option traders are back in Ziopharm Oncology after making quick profits last month. OptionMonster's Heat Seeker system detected heavy buying in the March 13 calls Monday, with the initial blocks mostly pricing for 55 cents...
Benzinga  Feb 23  Comment 
On CNBC's Fast Money Halftime Report Final Trade, Joe Terranova recommended a long position in Newmont Mining Corp (NYSE: NEM). Stephen Weiss likes Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP). He thinks that another bid may come in. Josh Brown...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki